No Data
Express News | Universal Health International - Proposes to Consolidate Every 10 Existing Shares of $0.01 Each Into 1 Consolidated Share of $0.10 Each
UNI HEALTH (02211) intends to consolidate shares on a 10-for-1 basis.
UNI HEALTH (02211) announced that the Board of Directors recommends implementing a share consolidation, based on every 10 shares of the company's capital...
FOSUN PHARMA (02196.HK) plans to establish Henan Fujian to strengthen its layout in the health industry.
According to the announcement on April 25 by Gelonghui, FOSUN PHARMA (02196.HK) stated that on April 25, 2025, its subsidiary FOSUN Pingyao signed a partnership agreement with Shanghai Rehabilitation, FOSUN Technology and Fuyou Zhigang, aiming to jointly establish Henan Rehabilitation. The total amount of capital contribution recognized by Henan Rehabilitation is RMB 10 million, among which: FOSUN Pingyao (as a limited partner) intends to contribute RMB 4.9 million in Cash / Money Market, Shanghai Rehabilitation (as a general partner) intends to contribute RMB 0.1 million in Cash / Money Market, and FOSUN Technology (as a limited partner) intends to contribute RMB 2.9 million in Cash / Money Market.
Has the SSE Health Care theme Index risen again? This year, the public fund performance has shuffled, with the highest return of the health care theme Fund exceeding 44%, and Inflow of capital has accelerated.
As of April 16, two SSE Health Care theme Index Funds have entered the top 10 performances of actively managed equity funds this year; Since April, multiple Hwabao WP CSI Medical Service ETFs have seen significant net subscriptions, with the total amount of fund shares for these medical ETFs reaching a new high; Fund managers believe that the pharmaceutical sector is not just undervalued in parts, but is comprehensively undervalued, and the nature of Innovative Drugs has changed.
Universal Health International Group Holding's (HKG:2211) Earnings Might Not Be As Promising As They Seem
UNI HEALTH: 2024/25 Interim Report